Neuropsychopharmacology and the Affective Disorders
- 24 July 1969
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 281 (4) , 197-201
- https://doi.org/10.1056/nejm196907242810405
Abstract
DRUGS that are clinically effective in the treatment of the affective disorders — depressions and manias — have also been found to be important tools for research in psychiatry during the past decade.1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Since these disorders, particularly the depressions, represent a heterogeneous collection of entities, their differential diagnosis and classification have occasioned a long standing controversy.18 , 19 A discussion of the diagnosis and classifications of the affective disorders is necessary, however, if the action of the agents developed to treat them is to be understood.Diagnosis and Classifications of the Affective DisordersThe term "depression" as it is commonly used in . . .Keywords
This publication has 36 references indexed in Scilit:
- A Comparative Trial of Imipramine and Chlorpromazine in Depressed PatientsThe British Journal of Psychiatry, 1968
- PROPHYLACTIC LITHIUM: ANOTHER THERAPEUTIC MYTH?The Lancet, 1968
- PREFACEActa Psychiatrica Scandinavica, 1966
- Prognostic Factors in Treatment of Depressive States with ImipramineBMJ, 1962
- Clinical Syndromes in Depressive StatesJournal of Mental Science, 1959
- Prognostic Factors in the Electro-Shock Treatment of Depressive StatesJournal of Mental Science, 1959
- Prognostic Factors in the Electroshock Treatment of Depressive StatesJournal of Mental Science, 1959
- Effects of Iproniazid in Depressive SyndromesBMJ, 1959
- HYPERTENSION PRODUCED WITH BENZEDRINE: ITS PSYCHOLOGICAL ACCOMPANIMENTSThe Lancet, 1936
- Melancholia: A Historical ReviewJournal of Mental Science, 1934